Works by Toyoda, Hidenori
Results: 332
Efficacy of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma in immunotherapy era clinical practice.
- Published in:
- Hepatology Research, 2025, v. 55, n. 3, p. 444, doi. 10.1111/hepr.14136
- By:
- Publication type:
- Article
Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort Study.
- Published in:
- Journal of Clinical & Translational Hepatology, 2024, v. 12, n. 7, p. 646, doi. 10.14218/JCTH.2024.00089
- By:
- Publication type:
- Article
Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
- Published in:
- Cancer Reports, 2024, v. 7, n. 4, p. 1, doi. 10.1002/cnr2.2042
- By:
- Publication type:
- Article
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience.
- Published in:
- Cancer Reports, 2022, v. 5, n. 2, p. 1, doi. 10.1002/cnr2.1464
- By:
- Publication type:
- Article
Direct‐acting antiviral therapy for chronic hepatitis C virus genotype 4 infection: Exploring new regimens.
- Published in:
- Health Science Reports, 2019, v. 2, n. 3, p. N.PAG, doi. 10.1002/hsr2.106
- By:
- Publication type:
- Article
Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development.
- Published in:
- Pathology International, 2010, v. 60, n. 5, p. 351, doi. 10.1111/j.1440-1827.2010.02526.x
- By:
- Publication type:
- Article
Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-78539-4
- By:
- Publication type:
- Article
Heat shock protein 20 (HSPB6) regulates apoptosis in human hepatocellular carcinoma cells: Direct association with Bax.
- Published in:
- Oncology Reports, 2014, v. 32, n. 3, p. 1291, doi. 10.3892/or.2014.3278
- By:
- Publication type:
- Article
Safety and complications of interventional radiology for hepatocellular carcinoma in patients....
- Published in:
- British Journal of Haematology, 2001, v. 112, n. 4, p. 1071, doi. 10.1046/j.1365-2141.2001.02606.x
- By:
- Publication type:
- Article
Infection with TT virus, a novel transfusion-transmissible DNA virus, in haemophiliacs and in blood products.
- Published in:
- British Journal of Haematology, 1999, v. 105, n. 4, p. 1114, doi. 10.1046/j.1365-2141.1999.01452.x
- By:
- Publication type:
- Article
Immune-related Liver Injury is a Poor Prognostic Factor in Patients with Nonsmall Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
- Published in:
- Cancer Investigation, 2022, v. 40, n. 2, p. 189, doi. 10.1080/07357907.2021.1994586
- By:
- Publication type:
- Article
Circulating Exosomal miRNA Profiles Predict the Occurrence and Recurrence of Hepatocellular Carcinoma in Patients with Direct-Acting Antiviral-Induced Sustained Viral Response.
- Published in:
- Biomedicines, 2019, v. 7, n. 4, p. 87, doi. 10.3390/biomedicines7040087
- By:
- Publication type:
- Article
Effect of previous infection with hepatitis B virus on the incidence of hepatocellular carcinoma after sustained virologic response in patients with chronic hepatitis C virus infection.
- Published in:
- Journal of Viral Hepatitis, 2024, v. 31, n. 3, p. 137, doi. 10.1111/jvh.13907
- By:
- Publication type:
- Article
Factors linked to hepatocellular carcinoma development beyond 10 years after viral eradication in patients with hepatitis C virus.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 10, p. 919, doi. 10.1111/jvh.13728
- By:
- Publication type:
- Article
International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 807, doi. 10.1111/jvh.13717
- By:
- Publication type:
- Article
Long‐term outcomes of viral eradication in patients with hepatitis C virus infection and mild hepatic fibrosis.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 9, p. 1293, doi. 10.1111/jvh.13562
- By:
- Publication type:
- Article
Long‐term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus–related decompensated cirrhosis.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 3, p. 508, doi. 10.1111/jvh.13457
- By:
- Publication type:
- Article
Comparison of liver disease state progression in patients with eradication of versus persistent infection with hepatitis C virus: Markov chain analysis.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 3, p. 538, doi. 10.1111/jvh.13444
- By:
- Publication type:
- Article
Impact of direct‐acting antiviral agents on liver function in patients with chronic hepatitis C virus infection.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 1, p. 168, doi. 10.1111/jvh.13408
- By:
- Publication type:
- Article
Evaluation of 8‐week glecaprevir/pibrentasvir treatment in direct‐acting antiviral‐naïve noncirrhotic HCV genotype 1 and 2infected patients in a real‐world setting in Japan.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 11, p. 1266, doi. 10.1111/jvh.13170
- By:
- Publication type:
- Article
Late relapse of hepatitis C virus in patients with sustained virological response after daclatasvir and asunaprevir therapy.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 12, p. 1446, doi. 10.1111/jvh.12967
- By:
- Publication type:
- Article
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial.
- Published in:
- Journal of Viral Hepatitis, 2014, v. 21, n. 11, p. 762, doi. 10.1111/jvh.12312
- By:
- Publication type:
- Article
Characteristics and Outcomes of HCV Genotype-1-Infected Patients Treated with Peginterferon and Ribavirin Combination Therapy with Discordant HCV Responses 4 and 12 Weeks after Starting Therapy.
- Published in:
- Intervirology, 2014, v. 57, n. 5, p. 289, doi. 10.1159/000362721
- By:
- Publication type:
- Article
Prevalence of Hepatitis E Virus IgG Antibody in Japanese Patients with Hemophilia.
- Published in:
- Intervirology, 2008, v. 51, n. 1, p. 21, doi. 10.1159/000118792
- By:
- Publication type:
- Article
Prevalence of Low-Level Hepatitis B Viremia in Patients with HBV Surface Antigen-Negative Hepatocellular Carcinoma with and without Hepatitis C Virus Infection in Japan: Analysis by COBAS TaqMan Real-Time PCR.
- Published in:
- Intervirology, 2007, v. 50, n. 4, p. 241, doi. 10.1159/000101911
- By:
- Publication type:
- Article
Treatment of Chronic Hepatitis C with Interferon Alone or Combined with Ribavirin in Japan.
- Published in:
- Intervirology, 2006, v. 49, n. 1/2, p. 112, doi. 10.1159/000087273
- By:
- Publication type:
- Article
Pretreatment gamma‐glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs.
- Published in:
- Kaohsiung Journal of Medical Sciences, 2024, v. 40, n. 2, p. 188, doi. 10.1002/kjm2.12771
- By:
- Publication type:
- Article
Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Reply to: Comment on: 'Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 6, p. 602, doi. 10.1159/000480256
- By:
- Publication type:
- Article
Ability of Cytokeratin-18 Fragments and FIB-4 Index to Diagnose Overall and Mild Fibrosis Nonalcoholic Steatohepatitis in Japanese Nonalcoholic Fatty Liver Disease Patients.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 6, p. 521, doi. 10.1159/000480142
- By:
- Publication type:
- Article
Trends and Efficacy of Interferon-Free Anti–hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 5, p. N.PAG, doi. 10.1093/ofid/ofz185
- By:
- Publication type:
- Article
Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 11, p. N.PAG, doi. 10.1093/ofid/ofy268
- By:
- Publication type:
- Article
Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed‐effects regression model approach.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 24, p. 21680, doi. 10.1002/cam4.6726
- By:
- Publication type:
- Article
Adverse events as potential predictive factors of therapeutic activity in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 7772, doi. 10.1002/cam4.5535
- By:
- Publication type:
- Article
New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 6980, doi. 10.1002/cam4.5495
- By:
- Publication type:
- Article
Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non‐viral infection: A Japanese multicenter observational study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 5, p. 5293, doi. 10.1002/cam4.5337
- By:
- Publication type:
- Article
The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC‐GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 4, p. 4259, doi. 10.1002/cam4.5294
- By:
- Publication type:
- Article
Does first‐line treatment have prognostic impact for unresectable HCC?—Atezolizumab plus bevacizumab versus lenvatinib.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 1, p. 325, doi. 10.1002/cam4.4854
- By:
- Publication type:
- Article
The prognosis of elderly patients with hepatocellular carcinoma: A multi‐center 19‐year experience in Japan.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 1, p. 345, doi. 10.1002/cam4.4850
- By:
- Publication type:
- Article
Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 20, p. 3796, doi. 10.1002/cam4.4763
- By:
- Publication type:
- Article
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 8, p. 3719, doi. 10.1002/cam4.2241
- By:
- Publication type:
- Article
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 1, p. 137, doi. 10.1002/cam4.1909
- By:
- Publication type:
- Article
Changes in highly sensitive alpha-fetoprotein for the prediction of the outcome in patients with hepatocellular carcinoma after hepatectomy.
- Published in:
- Cancer Medicine, 2014, v. 3, n. 3, p. 643, doi. 10.1002/cam4.218
- By:
- Publication type:
- Article
Modified FIB-4 Index in Type 2 Diabetes Mellitus with Steatosis: A Non-Linear Predictive Model for Advanced Hepatic Fibrosis.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 22, p. 2500, doi. 10.3390/diagnostics14222500
- By:
- Publication type:
- Article
Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 8, p. 579, doi. 10.3390/diagnostics10080579
- By:
- Publication type:
- Article
New scoring system combining the FIB-4 index and cytokeratin-18 fragments for predicting steatohepatitis and liver fibrosis in patients with nonalcoholic fatty liver disease.
- Published in:
- Biomarkers, 2018, v. 23, n. 4, p. 328, doi. 10.1080/1354750X.2018.1425915
- By:
- Publication type:
- Article